Biophysical Mapping of the Adenosine A2A Receptor

被引:85
|
作者
Zhukov, Andrei [1 ]
Andrews, Stephen P. [1 ]
Errey, James C. [1 ]
Robertson, Nathan [1 ]
Tehan, Benjamin [1 ]
Mason, Jonathan S. [1 ]
Marshall, Fiona H. [1 ]
Weir, Malcolm [1 ]
Congreve, Miles [1 ]
机构
[1] Heptares Therapeut Ltd, Welwyn Garden City AL7 3AX, Herts, England
关键词
PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; ANTAGONISTS; THERMOSTABILIZATION; STABILITY; BINDING; MODELS; POTENT; GPCR;
D O I
10.1021/jm2003798
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new approach to generating information on ligand receptor interactions within the binding pocket of G protein-coupled receptors has been developed, called Biophysical Mapping (BPM). Starting from a stabilized receptor (StaR), minimally engineered for thermostability, additional single mutations are then added at positions that could be involved in small molecule interactions. The StaR and a panel of binding site mutants are captured onto Biacore chips to enable characterization of the binding of small molecule ligands using surface plasmon resonance (SPR) measurement. A matrix of binding data for a set of ligands versus each active site mutation is then generated, providing specific affinity and kinetic information (K-D, k(on), and k(off)) of receptor-ligand interactions. This data set, in combination with molecular modeling and docking, is used to map the small molecule binding site for each class of compounds. Taken together, the many constraints provided by these data identify key protein-ligand interactions and allow the shape of the site to be refined to produce a high quality three-dimensional picture of ligand binding, thereby facilitating structure based drug design. Results of biophysical mapping of the adenosine A(2A) receptor are presented.
引用
下载
收藏
页码:4312 / 4323
页数:12
相关论文
共 50 条
  • [21] Immunotherapy and the A2A Adenosine Receptor: A Confounding Brew
    Strohbehn, Garth W.
    Ratain, Mark J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (03) : 498 - 500
  • [22] Role of Cholesterol in Adenosine A2A Receptor Activity
    Robinson, Anne S.
    McGraw, Claire
    Lyman, Edward R.
    Arnarez, Clement
    Rouviere, Eric
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 1A - 1A
  • [23] Allosteric modulation of the adenosine A2A receptor by cholesterol
    Huang, Shuya Kate
    Almurad, Omar
    Pejana, Reizel J.
    Morrison, Zachary A.
    Pandey, Aditya
    Picard, Louis-Philippe
    Nitz, Mark
    Sljoka, Adnan
    Prosser, R. Scott
    ELIFE, 2022, 11
  • [24] A covalent antagonist for the human adenosine A2A receptor
    Xue Yang
    Guo Dong
    Thomas J.M. Michiels
    Eelke B. Lenselink
    Laura Heitman
    Julien Louvel
    Ad P. IJzerman
    Purinergic Signalling, 2017, 13 : 191 - 201
  • [25] The A2A adenosine receptor mediates coronary vasodilation
    Belardinelli, L
    Shryock, JC
    Snowdy, S
    Zhang, Y
    Monopoli, A
    Lozza, G
    Ongini, E
    Olsson, RA
    Dennis, DM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 284 (03): : 1066 - 1073
  • [26] CoMFA study on adenosine A2A receptor agonists
    Doytchinova, I
    Valkova, I
    Natcheva, R
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 2001, 20 (02): : 124 - 129
  • [27] Molecular Modeling of the Human A2a Adenosine Receptor
    A. A. Ivanov
    I. I. Baskin
    V. A. Palyulin
    N. S. Zefirov
    Doklady Biochemistry and Biophysics, 2003, 389 (1-6) : 94 - 97
  • [28] The Crystallographic Model of a Human A2A Adenosine Receptor
    Jaakola, Veli-Pekka
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2010, 66 : S13 - S13
  • [29] Highest resolution achieved for adenosine A2A receptor
    Sklan, Alexandra
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (14) : 1777 - 1777
  • [30] Medicinal chemistry of adenosine A2A receptor agonists
    Cristalli, G
    Lambertucci, C
    Taffi, S
    Vittori, S
    Volpini, R
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (04) : 387 - 401